2 results
Approved WMOPending
Concluding, the aim of current study is to show feasibility of the MaMaLoc technology for surgical localization of clinically occult melanoma lesions, as well as to show feasibility of the MaMaLoc technology for lymph node detection, both in the…
Approved WMOCompleted
To compare the effect of semaglutide 1.0 mg once-weekly versus exenatide extended release (ER) 2.0 mg once-weekly on glycaemic control after 56 weeks of treatment.